Roflumilast (Daliresp)


Indications

Severe Chronic Obstructive Pulmonary Disease (COPD) Associated with Chronic Bronchitis and History of Exacerbations (see Chronic Obstructive Pulmonary Disease, [[Chronic Obstructive Pulmonary Disease]])


Pharmacology

Metabolism

Pharmacokinetics


Administration

Dose Adjustment

Drug Interaction


Adverse Effects

Gastrointestinal Adverse Effects

Other Adverse Effects


References